CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,525,080 | +74024.7% | 2,029,780 | +6.1% | 0.00% | -50.0% |
| Q4 2022 | $11,501 | -99.9% | 1,913,754 | +7.6% | 0.00% | 0.0% |
| Q3 2022 | $10,353,000 | +9.2% | 1,778,969 | +12.0% | 0.00% | +100.0% |
| Q2 2022 | $9,483,000 | +161.2% | 1,588,547 | +104.3% | 0.00% | – |
| Q1 2022 | $3,631,000 | +114.6% | 777,616 | +13.9% | 0.00% | – |
| Q4 2021 | $1,692,000 | -12.9% | 682,626 | +3.6% | 0.00% | – |
| Q3 2021 | $1,943,000 | +32.0% | 658,826 | +11.8% | 0.00% | – |
| Q2 2021 | $1,472,000 | +4.8% | 589,150 | +22.1% | 0.00% | – |
| Q1 2021 | $1,404,000 | +1.2% | 482,648 | +12.0% | 0.00% | – |
| Q4 2020 | $1,388,000 | +55.1% | 431,081 | +3.5% | 0.00% | – |
| Q3 2020 | $895,000 | +82.3% | 416,437 | -1.7% | 0.00% | – |
| Q2 2020 | $491,000 | +28.5% | 423,585 | +1.8% | 0.00% | – |
| Q1 2020 | $382,000 | -69.9% | 416,013 | -48.2% | 0.00% | – |
| Q4 2019 | $1,268,000 | +239.0% | 803,486 | +78.7% | 0.00% | – |
| Q3 2019 | $374,000 | -4.6% | 449,754 | -1.5% | 0.00% | – |
| Q2 2019 | $392,000 | -35.9% | 456,654 | -27.6% | 0.00% | – |
| Q1 2019 | $612,000 | -34.1% | 631,113 | -50.1% | 0.00% | – |
| Q4 2018 | $928,000 | -31.5% | 1,265,454 | +101.7% | 0.00% | – |
| Q3 2018 | $1,355,000 | -47.0% | 627,513 | +22.3% | 0.00% | -100.0% |
| Q2 2018 | $2,555,000 | +116.2% | 513,223 | +69.3% | 0.00% | – |
| Q1 2018 | $1,182,000 | +270.5% | 303,229 | +154.0% | 0.00% | – |
| Q4 2017 | $319,000 | -48.5% | 119,387 | -38.7% | 0.00% | – |
| Q3 2017 | $620,000 | +64.9% | 194,685 | +71.3% | 0.00% | – |
| Q2 2017 | $376,000 | -23.7% | 113,682 | -3.3% | 0.00% | – |
| Q1 2017 | $493,000 | – | 117,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |